GN

Gary J. Nabel

GS Glaxosmithkline Biologicals Sa: 1 patents #51 of 108Top 50%
II International Aids Vaccine Initiative: 1 patents #8 of 33Top 25%
SR Scripps Research: 1 patents #14 of 92Top 20%
US US Dept of Health & Human Services: 1 patents #1 of 14Top 8%
📍 East Sharon, MA: #4 of 15 inventorsTop 30%
🗺 Massachusetts: #327 of 12,163 inventorsTop 3%
Overall (2016): #20,143 of 481,213Top 5%
6
Patents 2016

Issued Patents 2016

Showing 1–6 of 6 patents

Patent #TitleCo-InventorsDate
9526777 Methods for the induction of ebola virus-specific immune responses comprising administering a replication-defective chimpanzee adenovirus vector expressing the ebola virus glycoprotein Nancy Sullivan, Clement Asiedu, Cheng Cheng, Alfredo Nicosia, Riccardo Cortese +2 more 2016-12-27
9487563 Virus-like particles and methods of use Srinivas Rao, Wataru Akahata 2016-11-08
9475862 Neutralizing GP41 antibodies and their use Mark Connors, Jinghe Huang, Leo B. Laub, Peter Kwong, John Mascola +6 more 2016-10-25
9441019 Influenza hemagglutinin protein-based vaccines Masaro Kanekiyo, Chih-Jen Wei, Patrick MCTAMNEY, II, Hadi M. Yassine, Jeffrey Boyington 2016-09-13
9382311 HIV-1 broadly neutralizing antibodies John Mascola, Dennis R. Burton, Wayne Koff, Peter Kwong, Sanjay K. Phogat +5 more 2016-07-05
9353353 Virus-like particles (VLPs) prepared from chikungunya virus structural proteins Wataru Akahata, Srinivas Rao 2016-05-31